Viltepso Carves US DMD Position Despite Headwinds

 
• By Lisa Takagi
  
Viltepso has its US sales growing
VIltepso's US sales took off since 2020 launch after accelerated approval. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies